nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprobarbital—Amobarbital—CYP2A6—prostate cancer	0.00836	0.115	CrCbGaD
Aprobarbital—Phenobarbital—CYP2C18—prostate cancer	0.00825	0.114	CrCbGaD
Aprobarbital—Pentobarbital—CYP2A6—prostate cancer	0.00702	0.0969	CrCbGaD
Aprobarbital—Phenobarbital—CYP1B1—prostate cancer	0.00683	0.0941	CrCbGaD
Aprobarbital—Thiopental—CYP2E1—prostate cancer	0.00601	0.0829	CrCbGaD
Aprobarbital—Phenobarbital—CYP3A5—prostate cancer	0.00544	0.075	CrCbGaD
Aprobarbital—Phenobarbital—CYP2A6—prostate cancer	0.00526	0.0726	CrCbGaD
Aprobarbital—Pentobarbital—CYP2C19—prostate cancer	0.00494	0.0681	CrCbGaD
Aprobarbital—Thiopental—CYP3A4—prostate cancer	0.00378	0.0522	CrCbGaD
Aprobarbital—Phenobarbital—CYP2E1—prostate cancer	0.00374	0.0515	CrCbGaD
Aprobarbital—Phenobarbital—CYP2C19—prostate cancer	0.0037	0.051	CrCbGaD
Aprobarbital—Phenobarbital—CYP1A1—prostate cancer	0.00369	0.0508	CrCbGaD
Aprobarbital—Pentobarbital—CYP3A4—prostate cancer	0.00314	0.0433	CrCbGaD
Aprobarbital—Phenobarbital—CYP3A4—prostate cancer	0.00235	0.0325	CrCbGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—GNG5—prostate cancer	0.00179	0.00193	CbGpPWpGaD
Aprobarbital—GABRA6—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.00177	0.00191	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—GNG5—prostate cancer	0.00176	0.0019	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—PLCB2—prostate cancer	0.00175	0.00189	CbGpPWpGaD
Aprobarbital—GABRA4—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.00175	0.00188	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.00173	0.00187	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—PLCB2—prostate cancer	0.00173	0.00187	CbGpPWpGaD
Aprobarbital—GABRA6—Orphan transporters—PPARA—prostate cancer	0.00172	0.00186	CbGpPWpGaD
Aprobarbital—GABRA1—Orphan transporters—NCOA1—prostate cancer	0.00171	0.00185	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.00171	0.00185	CbGpPWpGaD
Aprobarbital—GRIA2—Neuronal System—ACHE—prostate cancer	0.0017	0.00184	CbGpPWpGaD
Aprobarbital—GABRA4—Orphan transporters—PPARA—prostate cancer	0.0017	0.00184	CbGpPWpGaD
Aprobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACB—prostate cancer	0.0017	0.00183	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.00169	0.00182	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—prostate cancer	0.00168	0.00181	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—SLC22A1—prostate cancer	0.00167	0.0018	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—RRAS—prostate cancer	0.00167	0.0018	CbGpPWpGaD
Aprobarbital—CHRNA4—Neuronal System—ACHE—prostate cancer	0.00165	0.00178	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—PLCB2—prostate cancer	0.00165	0.00178	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—SLC22A1—prostate cancer	0.00165	0.00178	CbGpPWpGaD
Aprobarbital—GRIA2—Neuronal System—PRKACB—prostate cancer	0.00163	0.00176	CbGpPWpGaD
Aprobarbital—GABRA1—Orphan transporters—RXRA—prostate cancer	0.00163	0.00176	CbGpPWpGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—ACHE—prostate cancer	0.00162	0.00175	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—ACHE—prostate cancer	0.00159	0.00172	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—GNG5—prostate cancer	0.00159	0.00172	CbGpPWpGaD
Aprobarbital—CHRNA4—Neuronal System—PRKACB—prostate cancer	0.00158	0.0017	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—SLC22A1—prostate cancer	0.00158	0.0017	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—GNG5—prostate cancer	0.00157	0.00169	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—ACHE—prostate cancer	0.00157	0.00169	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.00156	0.00169	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—PRKACB—prostate cancer	0.00156	0.00168	CbGpPWpGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.00155	0.00167	CbGpPWpGaD
Aprobarbital—GRIK2—Neuronal System—COMT—prostate cancer	0.00155	0.00167	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.00155	0.00167	CbGpPWpGaD
Aprobarbital—GRIA2—Transmission across Chemical Synapses—COMT—prostate cancer	0.00155	0.00167	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—PLCB2—prostate cancer	0.00154	0.00166	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.00152	0.00164	CbGpPWpGaD
Aprobarbital—GABRA5—Orphan transporters—PPARA—prostate cancer	0.00151	0.00163	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—PLCB2—prostate cancer	0.00151	0.00163	CbGpPWpGaD
Aprobarbital—CHRNA4—Transmission across Chemical Synapses—COMT—prostate cancer	0.0015	0.00162	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.0015	0.00162	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—GNG5—prostate cancer	0.0015	0.00162	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.0015	0.00162	CbGpPWpGaD
Aprobarbital—GABRA3—Orphan transporters—PPARA—prostate cancer	0.00149	0.0016	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—PLCB2—prostate cancer	0.00148	0.0016	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.00147	0.00159	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—SLC22A1—prostate cancer	0.00147	0.00158	CbGpPWpGaD
Aprobarbital—GABRA2—Orphan transporters—PPARA—prostate cancer	0.00146	0.00157	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—IL1RN—prostate cancer	0.00145	0.00156	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.00145	0.00156	CbGpPWpGaD
Aprobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.00144	0.00155	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—SLC22A1—prostate cancer	0.00144	0.00155	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—ACHE—prostate cancer	0.00142	0.00153	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.00142	0.00153	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—SLC22A1—prostate cancer	0.00142	0.00153	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.00141	0.00152	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—BAD—prostate cancer	0.00141	0.00152	CbGpPWpGaD
Aprobarbital—CHRNA7—Neuronal System—COMT—prostate cancer	0.00141	0.00152	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—ACHE—prostate cancer	0.0014	0.00151	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—GNG5—prostate cancer	0.0014	0.0015	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.0014	0.0015	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.00138	0.00149	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—GNG5—prostate cancer	0.00137	0.00148	CbGpPWpGaD
Aprobarbital—GABRA6—Orphan transporters—CREBBP—prostate cancer	0.00137	0.00148	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—APC—prostate cancer	0.00137	0.00148	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.00136	0.00147	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.00136	0.00147	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—PRKACB—prostate cancer	0.00136	0.00146	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—IRS1—prostate cancer	0.00135	0.00146	CbGpPWpGaD
Aprobarbital—GABRA4—Orphan transporters—CREBBP—prostate cancer	0.00135	0.00146	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—GNG5—prostate cancer	0.00135	0.00145	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—ESR2—prostate cancer	0.00134	0.00145	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.00134	0.00145	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.00134	0.00145	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—PRKACB—prostate cancer	0.00134	0.00144	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—ACHE—prostate cancer	0.00134	0.00144	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—TH—prostate cancer	0.00133	0.00144	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—GSK3B—prostate cancer	0.00131	0.00142	CbGpPWpGaD
Aprobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.00131	0.00141	CbGpPWpGaD
Aprobarbital—GABRA6—Transmission across Chemical Synapses—COMT—prostate cancer	0.00129	0.00139	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.00128	0.00138	CbGpPWpGaD
Aprobarbital—GABRA4—Transmission across Chemical Synapses—COMT—prostate cancer	0.00127	0.00137	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—PLCB2—prostate cancer	0.00127	0.00136	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—EGR1—prostate cancer	0.00126	0.00136	CbGpPWpGaD
Aprobarbital—GABRA1—Orphan transporters—PPARA—prostate cancer	0.00124	0.00134	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—ACHE—prostate cancer	0.00124	0.00134	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.00124	0.00133	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.00122	0.00132	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—ACHE—prostate cancer	0.00122	0.00132	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—MAP2K1—prostate cancer	0.00121	0.00131	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—SLC22A1—prostate cancer	0.00121	0.0013	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.0012	0.0013	CbGpPWpGaD
Aprobarbital—GABRA5—Orphan transporters—CREBBP—prostate cancer	0.0012	0.0013	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—ACHE—prostate cancer	0.0012	0.00129	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—GJA1—prostate cancer	0.0012	0.00129	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.00119	0.00129	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.00119	0.00129	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—PRKACB—prostate cancer	0.00119	0.00128	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—AR—prostate cancer	0.00119	0.00128	CbGpPWpGaD
Aprobarbital—GRIA2—Neuronal System—COMT—prostate cancer	0.00119	0.00128	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.00118	0.00127	CbGpPWpGaD
Aprobarbital—GABRA3—Orphan transporters—CREBBP—prostate cancer	0.00118	0.00127	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.00117	0.00126	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.00117	0.00126	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—PRKACB—prostate cancer	0.00117	0.00126	CbGpPWpGaD
Aprobarbital—GABRA2—Orphan transporters—CREBBP—prostate cancer	0.00116	0.00125	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.00115	0.00124	CbGpPWpGaD
Aprobarbital—CHRNA4—Neuronal System—COMT—prostate cancer	0.00115	0.00124	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.00115	0.00124	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.00115	0.00124	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—GNG5—prostate cancer	0.00115	0.00124	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—PRKACB—prostate cancer	0.00115	0.00124	CbGpPWpGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—COMT—prostate cancer	0.00113	0.00122	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.00112	0.00121	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—COMT—prostate cancer	0.00111	0.0012	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—JAK2—prostate cancer	0.0011	0.00119	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.0011	0.00119	CbGpPWpGaD
Aprobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.0011	0.00119	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—COMT—prostate cancer	0.00109	0.00118	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.00109	0.00117	CbGpPWpGaD
Aprobarbital—GRIK2—Transmission across Chemical Synapses—MDM2—prostate cancer	0.00108	0.00117	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.00108	0.00116	CbGpPWpGaD
Aprobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.00107	0.00115	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—prostate cancer	0.00104	0.00112	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.00104	0.00112	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—ACHE—prostate cancer	0.00102	0.0011	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.00102	0.0011	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.00101	0.00109	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.00101	0.00108	CbGpPWpGaD
Aprobarbital—GABRA1—Orphan transporters—CREBBP—prostate cancer	0.000988	0.00107	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—COMT—prostate cancer	0.000987	0.00106	CbGpPWpGaD
Aprobarbital—CHRNA7—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000986	0.00106	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000982	0.00106	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000982	0.00106	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—PRKACB—prostate cancer	0.000979	0.00106	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—COMT—prostate cancer	0.000975	0.00105	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000968	0.00104	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—CASP3—prostate cancer	0.000965	0.00104	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000964	0.00104	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.00096	0.00104	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.00095	0.00102	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000934	0.00101	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—COMT—prostate cancer	0.00093	0.001	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—CTNNB1—prostate cancer	0.00093	0.001	CbGpPWpGaD
Aprobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000917	0.000989	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.000917	0.000988	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000913	0.000985	CbGpPWpGaD
Aprobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000905	0.000976	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000899	0.000969	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000893	0.000963	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000888	0.000957	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.000877	0.000946	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000877	0.000945	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.000875	0.000943	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—COMT—prostate cancer	0.000866	0.000934	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000862	0.000929	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000855	0.000922	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—COMT—prostate cancer	0.000851	0.000917	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000846	0.000912	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000844	0.00091	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—SRC—prostate cancer	0.00084	0.000906	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—COMT—prostate cancer	0.000836	0.000901	CbGpPWpGaD
Aprobarbital—GRIK2—Neuronal System—MDM2—prostate cancer	0.00083	0.000895	CbGpPWpGaD
Aprobarbital—GRIA2—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000829	0.000894	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—STAT3—prostate cancer	0.00081	0.000874	CbGpPWpGaD
Aprobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000804	0.000867	CbGpPWpGaD
Aprobarbital—CHRNA4—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000804	0.000867	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000796	0.000859	CbGpPWpGaD
Aprobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.00079	0.000852	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000789	0.00085	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000786	0.000848	CbGpPWpGaD
Aprobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000776	0.000837	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000775	0.000835	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000761	0.000821	CbGpPWpGaD
Aprobarbital—CHRNA7—Neuronal System—MDM2—prostate cancer	0.000755	0.000814	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—GNG5—prostate cancer	0.00075	0.000809	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000745	0.000803	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000737	0.000794	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000735	0.000792	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000729	0.000786	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000724	0.000781	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.00072	0.000776	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.000715	0.00077	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—COMT—prostate cancer	0.000713	0.000769	CbGpPWpGaD
Aprobarbital—GABRA6—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000689	0.000743	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000688	0.000741	CbGpPWpGaD
Aprobarbital—GABRA4—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000681	0.000734	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000679	0.000732	CbGpPWpGaD
Aprobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000662	0.000714	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000656	0.000707	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000649	0.0007	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000648	0.000698	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.00064	0.00069	CbGpPWpGaD
Aprobarbital—GRIA2—Neuronal System—MDM2—prostate cancer	0.000635	0.000685	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000632	0.000681	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000628	0.000677	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000617	0.000666	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000617	0.000666	CbGpPWpGaD
Aprobarbital—CHRNA4—Neuronal System—MDM2—prostate cancer	0.000616	0.000664	CbGpPWpGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000605	0.000652	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000603	0.00065	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000594	0.00064	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000592	0.000639	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000584	0.000629	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000582	0.000628	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000579	0.000625	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000575	0.00062	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000572	0.000617	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.000568	0.000612	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000565	0.000609	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000555	0.000599	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000551	0.000594	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000544	0.000587	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.000543	0.000586	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—MDM2—prostate cancer	0.000528	0.000569	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000526	0.000568	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000524	0.000565	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—AKT1—prostate cancer	0.000522	0.000563	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—MDM2—prostate cancer	0.000521	0.000562	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000515	0.000555	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000508	0.000548	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000499	0.000538	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000498	0.000537	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000496	0.000535	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000491	0.000529	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000487	0.000525	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000483	0.000521	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000475	0.000512	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000474	0.000511	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000467	0.000503	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—MDM2—prostate cancer	0.000463	0.0005	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000461	0.000497	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—MDM2—prostate cancer	0.000455	0.000491	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—MDM2—prostate cancer	0.000447	0.000482	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000421	0.000454	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000418	0.000451	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000416	0.000448	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000398	0.000429	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—MDM2—prostate cancer	0.000381	0.000411	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000369	0.000398	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000363	0.000391	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000356	0.000384	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000334	0.00036	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.00033	0.000356	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000319	0.000344	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000304	0.000328	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000293	0.000316	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000288	0.00031	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000283	0.000305	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000241	0.00026	CbGpPWpGaD
